Aldevron News

In the News: Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline

Moderna, Inc. (Nasdaq:MRNA), and Aldevron have announced their expanded collaboration in support of the Moderna COVID-19 Vaccine and additional programs in Moderna’s clinical development pipeline. Specifically, Aldevron will supply plasmid DNA to serve as the genetic template for generating the COVID-19 mRNA vaccine and other investigational programs in Moderna’s pipeline.

You can read the full press release on Moderna's Newsroom.

This partnership was also covered by Patrick Springer at Fargo, North Dakota's Inforum. A subscription may be required to view this article.

Topics: Plasmid DNA, Clinical Grade Manufacturing/cGMP, Partnerships, Vaccines